New publications: ALTEX and Human Vaccines & Immunotherapeutics

This year begins with the good news that two of our manuscripts have been accepted for publication. Stefan Vaessen and co-workers report on the results of a study, aiming to establish an innovative in-vitro approach to evaluate safety of pertussis (kinkhoest) vaccine. Teunis and co-workers report on a validation study, in which they studied the predictive value and reproducibility of a skin model to assess skin sensitizer potency of chemicals.